迪安診斷(300244.SZ):2019年淨利預降10%-16%
格隆匯2月3日丨迪安診斷(300244.SZ)披露2019年年度業績預告,公司預計2019年1-12月實現歸屬於上市公司股東的淨利潤3.26億元-3.50億元,同比下降16%-10%。業績變動原因説明:
1、報告期內,公司持續推進“醫學診斷整體化服務提供商”戰略,積極落實“有利潤的收入,有現金流的利潤”的經營指導思想,以技術創新加速企業升級,強化生物質譜和基因檢測技術的研發和應用,持續深化腫瘤、感染、婦幼等學科建設,進一步增強公司核心競爭力,推進公司的高質量發展。在保持業務增長的同時,加強營運資本精益管理,經營性現金流在上年同期的基礎上持續改善。
2、根據2019年度經營情況,公司從謹慎性角度出發認為新疆元鼎醫療器械有限公司等子公司存在商譽減值跡象,預計計提商譽減值準備約1.8億元,最終金額待審計、評估機構進行審評後方可確定。若剔除新疆元鼎業績及商譽減值的影響,則歸屬於上市公司股東的淨利潤比上年同期增長16%-23%。
3、預計2019年度非經常性損益對公司淨利潤的影響金額約為6200萬元-7500萬元,基本為對外投資股權處置收益及收到的政府補助。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.